Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

Journal:
Nature
Published:
DOI:
10.1038/s41586-021-04186-8
Affiliations:
24
Authors:
132
Institutions Authors Share
St Bartholomew's Hospital, United Kingdom (UK)
50.000000
50.000000
50.000000
50.000000
50.000000
50.000000
0.38
UCL, United Kingdom (UK)
32.000000
32.000000
32.000000
32.000000
0.24
UK Health Security Agency, United Kingdom (UK)
10.000000
10.000000
0.08
Imperial College London (ICL), United Kingdom (UK)
8.333333
0.06
Queen Mary University of London (QMUL), United Kingdom (UK)
7.500000
0.06
Royal Free London NHS Foundation Trust, United Kingdom (UK)
7.500000
0.06
Duke-NUS Medical School, Singapore
3.500000
0.03
William Harvey Research Institute (WHRI), QMUL, United Kingdom (UK)
3.000000
0.02
NIHR University College London Hospitals Biomedical Research Centre, United Kingdom (UK)
2.000000
0.02
University of Cambridge, United Kingdom (UK)
2.000000
0.02
Medway School of Pharmacy (MSP), United Kingdom (UK)
2.000000
0.02
Unit for Social and Community Psychiatry, QMUL, United Kingdom (UK)
1.000000
0.01
DZHK Partner Site Berlin, Germany
0.500000
0.00
Singapore Immunology Network (SIgN), A*STAR, Singapore
0.500000
0.00
Nottingham Biomedical Research Centre (BRC), United Kingdom (UK)
0.500000
0.00
Nottingham City Hospital, NUH, United Kingdom (UK)
0.500000
0.00
North West London Pathology, United Kingdom (UK)
0.500000
0.00
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)
0.333333
0.00
Royal Brompton and Harefield NHS Foundation Trust, United Kingdom (UK)
0.333333
0.00